1. A Phase II Trial of Abiraterone With Dutasteride for Second‐Generation Antiandrogen‐ and Chemotherapy‐Naïve Patients With Castration‐Resistant Prostate Cancer
   Masaki Shiota et al, 2023, The Journal of Clinical Pharmacology CrossRef
2. Physicochemical and Biopharmaceutical Controllability of New Self-Assembled Fatty Acid Conjugated Leuprolide for the Enhanced Anticancer Activity
   Hai V Ngo et al, 2023, International Journal of Nanomedicine CrossRef
3. Targeting tumor and bone microenvironment: Novel therapeutic opportunities for castration-resistant prostate cancer patients with bone metastasis
   Shenglong Li et al, 2024, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef